Calcium

Calcium

SCHEMBL30637044

Cc1ccc(F)c([C@H](C)Nc2nc(=O)n(C3CCOCC3)c(=O)[nH]2)c1.[Ca]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 2/20 0.42
▸ CHRM4 P08173 2/20 0.42
▸ CHRM5 P08912 2/20 0.42
▸ CHRM1 P11229 2/20 0.42
▸ CHRM3 P20309 2/20 0.42
▸ KCNH2 Q12809 2/20 0.42
▸ PIK3CB P42338 5/20 0.37
▸ NTRK1 P04629 2/20 0.37
▸ SOS1 Q07889 3/20 0.36
▸ PDE9A O76083 3/20 0.36
▸ KRAS P01116 2/20 0.36
▸ MTOR P42345 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ OPRL1 P41146 1/20 0.35
▸ JAK2 O60674 2/20 0.34
▸ JAK3 P52333 2/20 0.34
▸ JAK1 P23458 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29588826 0.99 CHRM2 (0.43) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL26344207 0.99 CHRM2 (0.43) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL26662006 0.99 CHRM2 (0.43) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL30637047 0.98 CHRM2 (0.42) CHRM2CHRM4CHRM5CHRM1CHRM3
Diethylamine SCHEMBL30637040 0.94 CHRM2 (0.39) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL30459661 0.90 PDE9A (0.39) NTRK1PDE9AMAPK1OPRM1OPRL1
SCHEMBL26344218 0.90 PDE9A (0.39) NTRK1PDE9AMAPK1OPRM1OPRL1
SCHEMBL30811374 0.84 IDH1 (0.42) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL26345799 0.83 CHRM2 (0.38) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL26345985 0.80 PDE2A (0.48) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117088854-A Pharmaceutically acceptable salts and crystal forms of triazinedione derivatives and preparation method thereof 江苏恒瑞医药股份有限公司 2023-11-21 — — CN disclosed
Send feedback